Copyright Reports & Markets. All rights reserved.

(Post-pandemic Era)-Global NGS Based Diagnostics Market Segment Research Report 2022

Buy now

Table of Contents

    Global NGS Based Diagnostics Market Segment Research Report 2022

      1. Research Scope

        2. Market Overview

        • 2.1 Product Introduction, Application, Picture
        • 2.2 Global NGS Based Diagnostics Market by Value
          • 2.2.1 Global NGS Based Diagnostics Revenue by Type
          • 2.2.2 Global NGS Based Diagnostics Market by Value (%)
        • 2.3 Global NGS Based Diagnostics Market by Production
          • 2.3.1 Global NGS Based Diagnostics Production by Type
          • 2.3.2 Global NGS Based Diagnostics Market by Production (%)

        3. The Major Driver of NGS Based Diagnostics Industry

        • 3.1 Historical & Forecast Global NGS Based Diagnostics Demand
        • 3.2 Largest Application for NGS Based Diagnostics (2018-2028)
        • 3.3 The Major Downstream Company in China Market 2022

        4. Global and Regional NGS Based Diagnostics Market

        • 4.1 Regional Market Size in Terms of Production & Demand (2022)
        • 4.2 Regional Market Share in Terms of Revenue (2018-2022)
        • 4.3 Concentration Ratio (CR5& CR10) of NGS Based Diagnostics Market
        • 4.4 Mergers & Acquisitions, Expansion Plans

        5. US NGS Based Diagnostics Production, Demand (2018-2028)

        • 5.1 Current and Estimated Production Breakdown by Type
        • 5.2 Current and Estimated Demand Breakdown by Type
        • 5.3 Current and Estimated Demand Breakdown by Application
        • 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        6. Europe NGS Based Diagnostics Production, Demand (2018-2028)

        • 6.1 Current and Estimated Production Breakdown by Type
        • 6.2 Current and Estimated Demand Breakdown by Type
        • 6.3 Current and Estimated Demand Breakdown by Application
        • 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        7. China NGS Based Diagnostics Production, Demand (2018-2028)

        • 7.1 Current and Estimated Production Breakdown by Type
        • 7.2 Current and Estimated Demand Breakdown by Type
        • 7.3 Current and Estimated Demand Breakdown by Application
        • 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        8. Japan NGS Based Diagnostics Production, Demand (2018-2028)

        • 8.1 Current and Estimated Production Breakdown by Type
        • 8.2 Current and Estimated Demand Breakdown by Type
        • 8.3 Current and Estimated Demand Breakdown by Application
        • 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        9. India NGS Based Diagnostics Production, Demand (2018-2028)

        • 9.1 Current and Estimated Production Breakdown by Type
        • 9.2 Current and Estimated Demand Breakdown by Type
        • 9.3 Current and Estimated Demand Breakdown by Application
        • 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        10. Korea NGS Based Diagnostics Production, Demand (2018-2028)

        • 10.1 Current and Estimated Production Breakdown by Type
        • 10.2 Current and Estimated Demand Breakdown by Type
        • 10.3 Current and Estimated Demand Breakdown by Application
        • 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        11. Southeast Asia NGS Based Diagnostics Production, Demand (2018-2028)

        • 11.1 Current and Estimated Production Breakdown by Type
        • 11.2 Current and Estimated Demand Breakdown by Type
        • 11.3 Current and Estimated Demand Breakdown by Application
        • 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        12. Global NGS Based Diagnostics Average Price Trend

        • 12.1 Market Price for Each Type of NGS Based Diagnostics in US (2018-2022)
        • 12.2 Market Price for Each Type of NGS Based Diagnostics in Europe (2018-2022)
        • 12.3 Market Price for Each Type of NGS Based Diagnostics in China (2018-2022)
        • 12.4 Market Price for Each Type of NGS Based Diagnostics in Japan (2018-2022)
        • 12.5 Market Price for Each Type of NGS Based Diagnostics in India (2018-2022)
        • 12.6 Market Price for Each Type of NGS Based Diagnostics in Korea (2018-2022)
        • 12.7 Market Price for Each Type of NGS Based Diagnostics in Southeast Asia (2018-2022)

        13. Industrial Chain (Impact of COVID-19)

        • 13.1 NGS Based Diagnostics Industrial Chain Analysis
        • 13.2 Downstream
        • 13.3 Impact of COVID-19
        • 13.4 Post-pandemic Era
        • 13.5 Technology Trends of NGS Based Diagnostics

        14. NGS Based Diagnostics Competitive Landscape

        • 14.1 Janssen
          • 14.1.1 Janssen Company Profiles
          • 14.1.2 Janssen Product Introduction
          • 14.1.3 Janssen NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.1.4 Strategic initiatives
        • 14.2 Roche
          • 14.2.1 Roche Company Profiles
          • 14.2.2 Roche Product Introduction
          • 14.2.3 Roche NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.2.4 Strategic initiatives
        • 14.3 Qiagen
          • 14.3.1 Qiagen Company Profiles
          • 14.3.2 Qiagen Product Introduction
          • 14.3.3 Qiagen NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.3.4 Strategic initiatives
        • 14.4 ThermoFisher Scientific
          • 14.4.1 ThermoFisher Scientific Company Profiles
          • 14.4.2 ThermoFisher Scientific Product Introduction
          • 14.4.3 ThermoFisher Scientific NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.4.4 Strategic initiatives
        • 14.5 Oxford Gene Technology
          • 14.5.1 Oxford Gene Technology Company Profiles
          • 14.5.2 Oxford Gene Technology Product Introduction
          • 14.5.3 Oxford Gene Technology NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.5.4 Strategic initiatives
        • 14.6 Illumina
          • 14.6.1 Illumina Company Profiles
          • 14.6.2 Illumina Product Introduction
          • 14.6.3 Illumina NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.6.4 Strategic initiatives
        • 14.7 Pacific Biosciences
          • 14.7.1 Pacific Biosciences Company Profiles
          • 14.7.2 Pacific Biosciences Product Introduction
          • 14.7.3 Pacific Biosciences NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.7.4 Strategic initiatives
        • 14.8 Paradigm Diagnostics
          • 14.8.1 Paradigm Diagnostics Company Profiles
          • 14.8.2 Paradigm Diagnostics Product Introduction
          • 14.8.3 Paradigm Diagnostics NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.8.4 Strategic initiatives
        • 14.9 Innogene Kalbiotech
          • 14.9.1 Innogene Kalbiotech Company Profiles
          • 14.9.2 Innogene Kalbiotech Product Introduction
          • 14.9.3 Innogene Kalbiotech NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.9.4 Strategic initiatives
        • 14.10 Admera Health
          • 14.10.1 Admera Health Company Profiles
          • 14.10.2 Admera Health Product Introduction
          • 14.10.3 Admera Health NGS Based Diagnostics Sales, Revenue (2018-2022)
          • 14.10.4 Strategic initiatives
        • 14.11 AITbiotech
        • 14.12 Centogene
        • 14.13 Phalanx Biotech Group
        • 14.14 iGenomX

        15. Conclusion

          16. Methodology and Data Source

          Summary

          The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

          2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

          According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

          Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global NGS Based Diagnostics Market Segment Research Report 2022》, which aims to sort out the development status and trends of the NGS Based Diagnostics industry at home and abroad, estimate the overall market scale of the NGS Based Diagnostics industry and the market share of major countries, NGS Based Diagnostics industry, and study and judge the downstream market demand of NGS Based Diagnostics through systematic research, Analyze the competition pattern of NGS Based Diagnostics, so as to help solve the pain points of various stakeholders in NGS Based Diagnostics industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

          Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of NGS Based Diagnostics Market by XYZResearch Include
          USA
          Europe
          China
          Japan
          India
          Korea
          Southeast Asia
          Competitive Analysis; Who are the Major Players in NGS Based Diagnostics Market?
          Janssen
          Roche
          Qiagen
          ThermoFisher Scientific
          Oxford Gene Technology
          Illumina
          Pacific Biosciences
          Paradigm Diagnostics
          Innogene Kalbiotech
          Admera Health
          AITbiotech
          Centogene
          Phalanx Biotech Group
          iGenomX
          Major Type of NGS Based Diagnostics Covered in XYZResearch report:
          DNA Sequencing
          RNA Sequencing
          Whole Genome Sequencing
          Whole Exome Sequencing
          Other
          Application Segments Covered in XYZResearch Market
          Hospitals
          Clinics
          Academics/Research Institutions

          For any other requirements, please feel free to contact us and we will provide you customized report.

          Buy now